Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Fusion Versus Cognitive MRI Targeted Prostatic Biopsy [NA]
A completed clinical trial comparing fusion MRI-targeted biopsy with cognitive MRI-targeted biopsy for prostate cancer is reported. The exce…
-
FDA approval · 2025-01-22FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) filed by Astellas Pharma US, expanding its labeling for use in prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer [Phase 1]
A Phase 1 trial evaluated oral BIBF 1120 (nintedanib) in combination with docetaxel and prednisone in patients with hormone-refractory prost…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.
Update on the Imperial Prostate 6 study, a cancer histology AI reliability trial sponsored by Imperial College London, currently not recruit…
-
CLINICAL_TRIALS trial_result · 2025-01-21Clinical Trial Update: STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer
A completed follow-up study evaluating men with prostate cancer on active surveillance as part of the STHLM3 AS NorDCaP trial.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-01-21Clinical Trial Update: A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab [Phase 1, Phase 2]
A Phase 1/2 study of evofosfamide in combination with zalifrelimab and balstilimab is currently recruiting for metastatic prostate cancer, m…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide [Phase 2]
This Phase 2 trial assesses pembrolizumab in patients with metastatic castration-resistant prostate cancer who were previously treated with …
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients [Phase 1, Phase 2]
A Phase 1/2 trial is planned to evaluate adjunctive rifaximin for preventing radiotherapy-induced diarrhea in cancer patients, including pro…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study. [Phase 4]
Phase 4 randomized study evaluating the Airseal System with ultra-low pneumoperitoneum in robot-assisted radical prostatectomy is currently …
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Prostate Cancer IRE Study (PRIS) [NA]
This clinical trial update indicates that the irreversible electroporation (IRE) study for prostate cancer (PRIS) is currently recruiting, s…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy [NA]
This document is a clinical trial update for a reminder app to optimize bladder filling in prostate cancer patients treated with hypo-fracti…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
ClinicalTrials.gov entry describing a study evaluating the diagnostic performance of the radiotracer [18F]PSMA-1007 for detecting recurrent …
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Investigation of Three Biomarkers for the Detection of Prostate Cancer
This clinical trial is investigating three biomarkers for detecting prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Genetic Studies of Prostate Cancer Aggressiveness and Prognosis
A completed Karolinska Institutet trial examining genetic factors associated with aggressiveness and prognosis in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer [Phase 4]
Phase 4 study evaluating 18F-Fluciclovine PET-CT to measure therapeutic response in metastatic prostate cancer; the trial was terminated and…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer [NA]
A completed clinical trial evaluating stereotactic body radiation therapy for prostate cancer has posted results on 2025-01-16.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating 18F-PSMA-1007 PET imaging for detecting primary prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating metronomic oral vinorelbine in combination with anti-PD-L1 and anti-CTLA-4 immunotherapy for patients …
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening [NA]
Clinical trial update on community interventions in non-medical settings to improve informed decision making for prostate cancer screening. …
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
This clinical trial registry entry outlines a study to assess ADC values and radiomics features from prostate MRI to identify tumor lesions.…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer
This clinical trial update describes recruitment to validate a magnetic resonance-based machine learning model for predicting prostate cance…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning [Phase 2]
An update on a phase 2 trial evaluating neoadjuvant pembrolizumab in non-metastatic prostate cancer, using 18FDG-PET biomarker guidance.
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Focal Therapy in Localized Prostate Cancer: a Prospective Registry
A prospective registry is being established to evaluate focal therapy for localized prostate cancer, with the trial currently not yet recrui…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death
This is an update on a completed non-interventional study evaluating time to event and healthcare resource use in prostate cancer participan…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial) [Phase 2]
The HypoPro trial is a Phase 2 study evaluating AI-driven personalization of radiotherapy in combination with androgen deprivation therapy f…